Gujarat Kidney IPO date, price, lot size & key details
Gujarat Kidney IPO Date, Price, Lot Size & Smart Investing Guide
The Gujarat Kidney & Super Speciality IPO is attracting a lot of buzz among retail investors because it combines the growth story of healthcare with the excitement of a fresh mainboard listing. The Gujarat Kidney IPO date is set between 22 December 2025 and 24 December 2025, with a price band of ₹108–₹114 per share, giving investors a new chance to participate in India’s expanding hospital sector.
Just like planning a surgery needs preparation, planning for an IPO investment also needs the right information, tools, and education so that you are not just following tips but making informed decisions.
Know Gujarat Kidney IPO date, Gujarat Kidney IPO price, lot size, key details and how a stock market course in India can help you invest smartly.
Gujarat Kidney IPO at a glance
The Gujarat Kidney & Super Speciality IPO is a mainboard book-built issue of around ₹250.8 crore through a complete fresh issue of 2.2 crore equity shares with face value ₹2 each. This means the company will receive all the IPO proceeds, which will be used to expand its hospital network and strengthen its balance sheet.
The IPO will list on both BSE and NSE, giving investors good liquidity once the shares start trading on the stock exchanges. For many first-time investors, this IPO could be their initial exposure to a specialised healthcare chain focusing on kidney and super-speciality services.
Gujarat Kidney IPO date and key timeline
The Gujarat Kidney IPO date for bidding is from 22 December 2025 to 24 December 2025, giving retail investors three days to apply. The basis of allotment is expected on 26 December 2025, with listing tentatively scheduled for 30 December 2025 on BSE and NSE.
Refunds and demat credit are likely to take place around 29 December 2025, so investors can see allotted shares in their demat accounts before listing. For anchor investors, the anchor portion is scheduled around 19 December 2025, just before the issue opens to the public.
Gujarat Kidney IPO price band, lot size and minimum investment
The Gujarat Kidney IPO price band is fixed at ₹108 to ₹114 per share, with a face value of ₹2. The IPO market lot is 128 shares, meaning the minimum application for retail investors is one lot of 128 shares.
- Minimum investment for retail: 1 lot × 128 shares × ₹114 (upper band) ≈ ₹14,592.
- Small HNI (sNII) minimum: 14 lots (1,792 shares), about ₹2,04,288 at upper band.
- Big HNI (bNII) minimum: 69 lots (8,832 shares), roughly ₹10,06,848 at upper band.
This structure allows small retail investors to participate with relatively modest capital, while also giving room to HNIs and institutions under standard mainboard allocation norms.
About Gujarat Kidney & Super Speciality Hospital
Gujarat Kidney & Super Speciality is a chain of mid-sized multispeciality hospitals located primarily in central Gujarat, with a focus on secondary and tertiary care surgical services. The company offers specialised renal (kidney-related) treatments as well as other super-speciality services and operates multiple hospitals with a combined capacity of around several hundred beds.
Led by promoter and Managing Director Dr. Pragnesh Yashwantsingh Bharpoda, the group positions itself as a regional healthcare provider offering integrated services, including surgeries and support services under one umbrella. This focused regional presence can help the company build a strong brand in its catchment area and maintain patient referrals.
Why this IPO is coming now
The company has filed its Draft Red Herring Prospectus (DRHP) with SEBI and is now launching the IPO as part of its expansion and consolidation strategy in Gujarat’s healthcare market. Healthcare in India is witnessing rising demand due to increasing lifestyle diseases, higher awareness and insurance coverage, and improving affordability in tier-2 and tier-3 cities.
By tapping the capital markets through this IPO, Gujarat Kidney aims to raise long-term funds without taking on heavy additional debt, allowing it to grow faster and compete better with larger hospital chains. For investors, this timing gives exposure to a niche hospital operator at a stage when it is actively expanding its network and capabilities.
How the IPO money will be used
The net proceeds from the Gujarat Kidney IPO will be deployed across several expansion and strategic initiatives. Key intended uses include:
- Acquisition of existing hospitals: A significant portion is earmarked for the proposed acquisition of Parekhs Hospital in Ahmedabad.
- Payment for already acquired assets: Part-payment of the purchase consideration for Ashwini Medical Centre, which has already been acquired.
- New hospital setup: Funding capital expenditure for setting up a new hospital in Vadodara.
- Robotics equipment: Buying robotics equipment for its Vadodara hospital to enhance surgical capabilities.
- Debt reduction and general corporate purposes: Partial repayment or prepayment of secured borrowings and funding inorganic growth as well as general corporate needs.
For an investor, understanding where the money goes is crucial because it shows whether the IPO is funding growth, paying down debt, or giving exits to existing shareholders.
Strengths of Gujarat Kidney as a business
Gujarat Kidney’s business model has some notable strengths that may appeal to investors looking at healthcare stories.
- Focused regional presence: Concentration in central Gujarat allows deeper penetration, better doctor networks, and brand recognition in the region.
- Super-speciality positioning: High-value surgical and super-speciality procedures can drive better margins compared to purely general care.
- Growth via acquisition and greenfield expansion: A balanced approach of acquiring existing hospitals and setting up new ones can accelerate scale.
- Improving financial profile: Available financial data indicates growth in EBITDA and PAT over recent periods, with healthy margins for a mid-sized hospital chain.
However, strengths alone should never be the only basis for investing; risks need equal attention.
Key risks to consider before applying
Even though the Gujarat Kidney IPO date and price might look attractive, every investor should carefully weigh the risks.
- Regional concentration risk: Heavy dependence on one state or region can expose the company to local regulatory, economic, or competitive pressures.
- Execution risk in expansion: Acquisitions and new hospitals require time to stabilise, and missteps can affect profitability and return on capital.
- Dependence on key doctors and specialists: In specialised healthcare, loss of key doctors or difficulty in attracting talent can impact operations.
- Regulatory and pricing risks: Healthcare is subject to changing regulations, price caps, and compliance requirements that may affect margins.
Being aware of these factors helps investors avoid the trap of investing just because an IPO is popular.
Who should consider investing in this IPO
The Gujarat Kidney IPO may suit certain investor profiles more than others, depending on risk appetite and investment horizon.
- Long-term investors who believe in the healthcare growth story and are comfortable with mid-sized regional operators may consider this as a satellite allocation in their portfolio.
- Investors familiar with IPOs and comfortable with listing volatility may try for potential listing gains, but this is always uncertain and should not be the sole reason to apply.
- New investors should preferably first learn the basics of IPO evaluation—through a structured stock market course in India—before committing large capital.
Matching the IPO risk profile with personal goals is as important as understanding the Gujarat Kidney IPO price band or lot size.
How to apply for Gujarat Kidney IPO step by step
Applying for the Gujarat Kidney IPO is straightforward if you already have a demat and trading account with a broker or a fintech platform.
- Step 1 – Log in to your broker app or website: Use platforms such as Zerodha, Groww, or your bank’s trading interface that support UPI-based IPO applications.
- Step 2 – Go to the IPO section: Locate the Gujarat Kidney & Super Speciality IPO in the ongoing issues list.
- Step 3 – Enter bid details: Choose the number of lots, select cut-off price (if allowed) or a specific price within the ₹108–₹114 band, and confirm your UPI ID.
- Step 4 – Approve the UPI mandate: Open your UPI app and approve the payment block request for the total amount.
- Step 5 – Wait for allotment: Funds remain blocked until allotment and are debited only if you receive shares; otherwise, they are unblocked.
This simple flow ensures even beginners can participate, as long as they double-check details before submitting.
Role of Gujarat Kidney IPO in a beginner’s portfolio
For a new investor, the Gujarat Kidney IPO should ideally be a small, exploratory position rather than the core of the portfolio. Diversification across sectors like banking, FMCG, IT, and healthcare helps reduce risk, instead of putting all money into one IPO.
Think of your portfolio like a balanced diet: Gujarat Kidney is one dish on the table, not the entire meal. A strong foundation with quality, already-listed stocks plus occasional, well-researched IPO participation can be a more sustainable approach.
Why a stock market course in India matters for IPO investing
Many beginners search for “stock market course in India” after facing confusion around terms like price band, GMP, or oversubscription. A good stock market course in India helps you understand how IPO pricing works, how to read financial statements, and how to judge business quality beyond headlines.
Such courses usually cover basics of fundamental analysis, IPO frameworks, risk management, and the role of macroeconomic factors, which can significantly improve your decision-making for issues like the Gujarat Kidney IPO date and other upcoming offers. Instead of blindly copying social media tips, structured learning helps you build your own logical checklist.
How to analyse healthcare IPOs like Gujarat Kidney
Healthcare IPOs have some unique factors compared to technology or manufacturing companies. When you look at Gujarat Kidney or any similar issue, some useful points include:
- Bed capacity and utilisation: Higher occupancy and better utilisation of operation theatres and equipment often support stronger revenues and margins.
- Case mix and payer mix: A balance of cash, insurance, and government scheme patients influences realisations; super-speciality cases typically yield higher revenue per patient.
- Expansion economics: Pay attention to how much capex is planned per bed and how long it takes for new hospitals to break even.
- Clinical reputation and doctor retention: In healthcare, reputation and doctor relationships are long-term competitive moats that cannot be built overnight.
Understanding these basics either through self-study or a structured stock market course in India can help you interpret IPO documents more confidently.
Simple checklist before you apply
Before applying on the Gujarat Kidney IPO date window, run through a quick checklist instead of acting purely on hype.
- Have you read at least one detailed review and the key risk factors from the RHP or trusted analysis sites?.
- Are you clear about the Gujarat Kidney IPO price band, lot size, and the total amount you are blocking via UPI?
- Does this IPO fit your risk profile, or are you overexposed to a single sector like hospitals or healthcare?
- Are you prepared for listing-day volatility, including the possibility of losses in the short term?
- Have you started or planned a stock market course in India to systematically build your knowledge for future IPOs and long-term investing?
If the answer to these questions is thoughtful and not rushed, your IPO decisions will likely be more grounded.
Final thoughts on Gujarat Kidney IPO date and your learning journey
The Gujarat Kidney IPO date of 22–24 December 2025 and the Gujarat Kidney IPO price band of ₹108–₹114 per share make this a noteworthy issue in the healthcare space for year-end primary markets. For retail investors, it represents both an opportunity to participate in a growing regional hospital chain and a reminder that proper education, via a reliable stock market course in India, is essential for sustainable success.
Treat this IPO not just as a one-time event, but as part of a broader journey where each investment teaches you something about sectors, businesses, and your own risk tolerance.
FAQs on Gujarat Kidney IPO
1. What is the Gujarat Kidney IPO date?
The Gujarat Kidney IPO date for bidding is from 22 December 2025 to 24 December 2025, with allotment expected on 26 December and listing around 30 December 2025.
2. What is the Gujarat Kidney IPO price band?
The Gujarat Kidney IPO price band is set at ₹108–₹114 per equity share, with a face value of ₹2 per share.
3. What is the lot size and minimum investment for retail investors?
The lot size is 128 shares, and the minimum investment for a retail investor is one lot, which comes to approximately ₹14,592 at the upper price band of ₹114.
4. How can a beginner apply for the Gujarat Kidney IPO?
A beginner can apply through their broker or fintech app by logging in, selecting the Gujarat Kidney IPO, entering the desired number of lots at cut-off or within the price band, and approving the UPI mandate to block funds.
5. Is a stock market course in India useful before investing in IPOs like Gujarat Kidney?
Yes, a structured stock market course in India can be very useful because it teaches IPO evaluation, risk management, and basic financial analysis, helping investors make more informed decisions instead of relying only on tips or social media trends.
